ARTICLE | Company News
Semaia Pharmaceuticals Holdings, Max-Delbrueck Center for Molecular Biology deal
October 1, 2001 7:00 AM UTC
Cancer therapeutics company Semaia (Berlin, Germany), a wholly-owned subsidiary of Semaia Pharmaceuticals, will work with the center to develop anti-tumor drugs. Semaia will receive an exclusive licen...